Chiral 3,3′-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4-thiazolidinones] with anti-inflammatory activity.: Part II:: Evaluation of COX-2 selectivity and modelling

被引:53
作者
Vigorita, MG
Ottanà, R
Monforte, F
Maccari, R
Monforte, MT
Trovato, A
Taviano, MF
Miceli, N
De Luca, G
Alcaro, S
Ortuso, F
机构
[1] Univ Messina, Dipartimento Farmaco Chim, Fac Farm, I-98168 Messina, Italy
[2] Univ Messina, Dipartimento Farmaco Biol, Fac Farm, I-98168 Messina, Italy
[3] Univ Messina, Ist Sci Biochim, Fac Med & Chirurg, Policlin Univ G Martino, I-98124 Messina, Italy
[4] Univ Messina, Biochim Clin, Fac Med & Chirurg, Policlin Univ G Martino, I-98124 Messina, Italy
[5] Univ Catanzaro Magna Graecia, Dipartimento Sci Farmacobiol, Catanzaro, Italy
关键词
D O I
10.1016/S0968-0896(02)00518-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Anti-inflammatory/analgesic 3,3'-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4-thiazolidinones] 1, obtained as racemic mixtures (a) and mesoforms (b), have two equivalent stereogenic centres (C-2 and C-2') and exist as RR, SS and RS isomers. The enantioseparation of la provided the single enantiomers that displayed different in vitro cyclooxygenase-1 /cyclooxygenase-2 selectivity ratios. In particular the dextrorotatory compound is a highly selective COX-2 inhibitor and the levorotatory one is moderately selective. Instead, RS-meso isomer (1b) exhibited similar levels of inhibitory activity on both COX isozymes. The diastereo- and enantioselectivity has been explained by molecular modelling of RR, SS and RS compounds into COX-1 and COX-2 binding sites. Theoretical results indicated SS > RS > RR affinity order towards COX-2 isoenzyme, in agreement with in vitro and previous in vivo pharmacological results. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:999 / 1006
页数:8
相关论文
共 40 条
[1]  
Alcaro S, 2000, J COMPUT CHEM, V21, P515, DOI 10.1002/(SICI)1096-987X(200005)21:7<515::AID-JCC2>3.0.CO
[2]  
2-5
[3]  
Amgad G., 2001, J MED CHEM, V44, P3039
[4]   Structure of COX-1 and COX-2 enzymes and their interaction with inhibitors [J].
Bakhle, YS .
DRUGS OF TODAY, 1999, 35 (4-5) :237-250
[5]   Structure-based design of COX-2 selectivity into flurbiprofen [J].
Bayly, CI ;
Black, WC ;
Léger, S ;
Ouimet, N ;
Ouellet, M ;
Percival, MD .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (03) :307-312
[6]   STRUCTURES OF THE CONFIGURATIONAL ISOMERS OF 3,3' (1,2-ETHANEDIYL)BIS[2(3-FLUOROPHENYL)-1,3-THIAZOLIDINE-4-ONE], C20H18F2N2O2S2 [J].
BENETOLLO, F ;
BOMBIERI, G ;
DELPRA, A ;
BASILE, M ;
PREVITERA, T ;
VIGORITA, MG .
JOURNAL OF CRYSTALLOGRAPHIC AND SPECTROSCOPIC RESEARCH, 1991, 21 (02) :113-120
[7]   LIQUID-CHROMATOGRAPHIC SEPARATION OF THE ENANTIOMERS OF ANTIHISTAMINIC 3,3'-DI(1,3-THIAZOLIDIN-4-ONE) DERIVATIVES WITH 2 AND 4 STEREOGENIC CENTERS [J].
CACCAMESE, S ;
PRINCIPATO, G ;
OTTANA, R ;
PREVITERA, T ;
ZAPPALA, C .
JOURNAL OF CHROMATOGRAPHY A, 1995, 694 (02) :355-363
[8]   Cyclooxygenase-2 selective inhibitors [J].
Cannon, GW .
DRUGS OF TODAY, 1999, 35 (07) :487-496
[9]   MECHANISM OF SELECTIVE-INHIBITION OF THE INDUCIBLE ISOFORM OF PROSTAGLANDIN G/H SYNTHASE [J].
COPELAND, RA ;
WILLIAMS, JM ;
GIANNARAS, J ;
NURNBERG, S ;
COVINGTON, M ;
PINTO, D ;
PICK, S ;
TRZASKOS, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :11202-11206
[10]  
Crow J P, 1995, Adv Pharmacol, V34, P17